Zepp Health Corporation
TechnologyNYSE:ZEPP · New York Stock Exchange
-$0.16 today
Vol 0.15M · Avg 0.14M
Cash Flow
Check whether earnings turn into cash
Use operating cash flow, capital spending, free cash flow, and financing activity to see how much value is left for reinvestment or owners.
Free Cash Flow
Net Income to FCF bridge
Analysis
Analysis will appear once cash flow data is available for this period.
Cash Flow Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$280.2M -269.6% | -$75.8M -143.9% | -$31.1M +28.3% | -$43.3M -131.9% | $136.0M | $487.6M | $476.4M | $465.2M |
| Depreciation & Amortization | $31.7M +532.1% | $5.0M -34.8% | $7.7M -11.7% | $8.7M -83.0% | $51.2M | $374.2M | $1.2B | $631.8M |
| Deferred Income Tax | $15.6M +16.4% | $13.4M +567.5% | -$2.9M +71.0% | -$9.9M +46.2% | -$18.5M | $1.4B | -$1.5B | $304.2M |
| Stock-Based Compensation | $17.4M +264.7% | $4.8M -45.7% | $8.8M +20.9% | $7.3M | $0 | $489.0M | $354.6M | -$1.6B |
| Change in Working Capital | -$110.0M -1535.1% | $7.7M -84.0% | $47.9M +158.2% | -$82.3M +86.7% | -$620.5M | $350.4M | -$1.6B | $1.5B |
| Accounts Receivables | -$80.7M -20070.5% | $404.0K -99.1% | $43.8M +1301.2% | $3.1M -99.0% | $300.8M | $592.6M | $1.3B | $626.2M |
| Inventory | -$154.5M -2880.9% | $5.6M -89.3% | $51.9M +85.9% | $27.9M +134.0% | -$82.0M | $1.0B | $1.2B | $1.1B |
| Accounts Payables | $197.9M +1235.9% | $14.8M +153.2% | -$27.8M +79.4% | -$135.3M +79.6% | -$664.5M | $948.2M | -$1.5B | $433.0M |
| Other Working Capital | -$72.7M -454.4% | -$13.1M +34.5% | -$20.0M -190.9% | $22.0M +112.6% | -$174.8M | $567.4M | $1.3B | $601.0M |
| Other Non-Cash Items | $145.7M +610.3% | $20.5M +68.0% | $12.2M +401.3% | $2.4M -98.0% | $120.0M | $1.4B | -$1.5B | $300.0M |
| Operating Cash Flow | -$179.7M -636.5% | -$24.4M -157.3% | $42.6M +136.4% | -$117.1M +64.7% | -$331.8M | $7.2B | $8.9B | $10.5B |
| Capital Expenditures | -$5.5M -267.9% | -$1.5M +11.3% | -$1.7M -13.9% | -$1.5M +96.8% | -$45.5M | $664.0M | $1.4B | $697.6M |
| Acquisitions (Net) | $0 | $0 -100.0% | $427.0K +611.7% | $60.0K -99.8% | $36.0M | $937.0M | $1.1B | $1.3B |
| Purchases of Investments | $0 +100.0% | -$7.0M -2381.6% | -$282.0K +93.5% | -$4.3M +99.6% | -$1.1B | $444.2M | $1.4B | $1.3B |
| Sales of Investments | $11.7M +126.1% | $5.2M -13.0% | $5.9M +229.6% | $1.8M -92.7% | $24.7M | $822.2M | $318.2M | -$1.5B |
| Other Investing Activities | $2.3M +37.7% | $1.7M -48.9% | $3.2M +226.6% | -$2.6M | $0 | $616.4M | $370.0M | $1.2B |
| Investing Cash Flow | $10.3M +755.4% | -$1.6M -120.4% | $7.7M +223.9% | -$6.2M +99.4% | -$1.1B | $4.8B | $6.4B | $5.1B |
| Debt Repayment | -$51.3M -3018.0% | -$1.6M +96.5% | -$47.0M -383.9% | $16.5M -97.5% | $654.6M | $680.8M | $759.2M | $1.1B |
| Common Stock Issued | $0 | $0 | $0 | $0 -100.0% | $5.4M | $778.8M | $946.8M | $812.4M |
| Common Stock Repurchased | -$8.7M -280.0% | -$2.3M +9.5% | -$2.5M +69.1% | -$8.2M +39.9% | -$13.6M | $351.8M | -$1.6B | $1.5B |
| Dividends Paid | $0 | $0 | $0 +100.0% | -$6.3M | $0 | $535.2M | $613.6M | $692.0M |
| Other Financing Activities | $233.6M +5209.3% | $4.4M -43.8% | $7.8M -80.6% | $40.3M | $0 | -$1.6B | $1.3B | $1.1B |
| Financing Cash Flow | $173.7M +36307.0% | $477.0K +101.1% | -$41.7M -198.4% | $42.4M -93.4% | $646.4M | $12.2B | $13.9B | -$15.5B |
| Effect of Forex Changes | $11.0M +359.7% | -$4.2M +54.4% | -$9.3M +37.0% | -$14.8M -144.1% | $33.5M | $1.3B | $1.1B | $990.2M |
| Net Change in Cash | $15.4M +151.7% | -$29.7M -4460.4% | -$652.0K +99.3% | -$95.8M +86.5% | -$707.5M | $3.2B | $4.9B | $6.5B |
| Free Cash Flow | -$185.1M -615.3% | -$25.9M -163.2% | $40.9M +134.5% | -$118.6M +68.6% | -$377.2M | $8.6B | -$16.8B | $11.1B |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Babcock & Wilcox Enterprises, Inc.
NYSE:BW
$1.84B
Silvaco Group, Inc. Common Stock
NASDAQ:SVCO
$397.73M
TROOPS, Inc.
NASDAQ:TROO
$304.18M
KULR Technology Group, Inc.
AMEX:KULR
$175.31M
Expensify, Inc.
NASDAQ:EXFY
$121.51M
TTEC Holdings, Inc.
NASDAQ:TTEC
$114.35M
Stem, Inc.
NYSE:STEM
$65.48M
Arrive AI Inc.
ARAI
$15.67M
X3 Holdings Co., Ltd.
XTKG
$575,474.00
SEC Filings
Recent regulatory filings
No filings found.
Does ZEPP generate free cash flow?
Zepp Health Corporation (ZEPP) generated -$185,136,077.00 of free cash flow in fiscal 2025.
How much operating cash flow does ZEPP produce?
Operating cash flow was -$179,653,879.00, before capital expenditures of $5.48M.
Explore More
Continue the stock analysis
Jump to another research area for this company.